XtalPi Holdings stock
Price history
−52.76% over the period1 year: from $10.16 (November 20, 2025) to $4.80 (November 20, 2026), −52.76%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | $4.80 |
| October 30, 2026 | $6.11 |
| September 30, 2026 | $8.18 |
| August 31, 2026 | $7.44 |
| July 31, 2026 | $6.84 |
| June 30, 2026 | $7.65 |
| May 29, 2026 | $8.24 |
| April 30, 2026 | $9.53 |
| March 31, 2026 | $9.01 |
| February 27, 2026 | $10.36 |
| January 30, 2026 | $12.08 |
| December 31, 2025 | $9.46 |
| November 28, 2025 | $10.01 |
| November 20, 2025 | $10.16 |
At a glance
The company
Operates an AI-driven research platform offering chemistry automation, molecular simulation, and drug discovery solutions
Latest results
Quarter to June 30, 2026 · EPS -¥0.06
TickerLandia's take on XtalPi Holdings
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−66.39% from the 52-week high
Analysts · 8 analysts
Average target$9.93+106.94% vs. price
Buy 6 · Hold 2 · Sell 0
TickerLandia Fingerprint: XtalPi Holdings
Compared with similar companies: very low earnings stability, very weak momentum, and very high risk.
Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.
Pricehigh74
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 146.8 99 Price/book 2.23 29 Price/sales 34.7 94 Profitabilitylow21
How much it earns on revenue and capital.
Metric Value Position in group ROE −2.1% 10 ROA −5.2% 6 Gross margin 51.5% 83 Operating marginabove 100%: likely one-off items −124.6% 3 Net margin −31.1% 1 Earnings stabilityvery low5
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 181.7% 3 Loss-making yearscounts in reverse: lower means more earnings stability 4 of 5 annual reports 6 Growthaverage49
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +81.90% 97 Revenue growth (year over year) −23.90% 1 Financial strengthaverage55
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Current ratio 2.94 90 Interest coverage −49.0 1 Debt/equitycounts in reverse: lower means more financial strength 0.34 73 Dividendno dividend
How much it returns to shareholders, and for how long.
Market momentumvery weak9
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (6 months) −30.46% 13 Relative strength (3 months) −31.58% 9 1-year return −52.76% 3 Distance from 200-day average −40.97% 10 Riskvery high83
How much the price swings.
Metric Value Position in group Beta (1 year) 1.35 78 Maximum drawdown (12 months) 65.6% 91 Volatility (60 days) 63.4% 82
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
XtalPi Holdings is pricier than similar companies
XtalPi Holdings's Forward P/E: 146.8, +466% against the median of a group of 5 similar companies (26.0).
Compared with 5 similar companies
| Metric | XtalPi Holdings | Position in the group | Band |
|---|---|---|---|
| Forward P/E | 146.8 | High | |
| Operating margin | -124.6% | Low | |
| ROE | -2.1% | Middle | |
| Debt/equity | 0.34 | Middle | |
| Price/book | 2.23 | Low |
Grey band: the middle half of the group; tick: the median; dot: XtalPi Holdings. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
¥393.63M
Latest quarter · Q2 2026
Net income
-¥251.9M
Latest quarter · Q2 2026
Quarterly net margin
-64.0%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- $23.54B
- EPS
- -$0.05
- Volume
- 41.73M
- Daily trading
- €27.43M
How XtalPi Holdings is changing
All resultsRevenue grew 81.9% a year on average over the last 3 years
Operating margin rose from −407.2% to −57.2%
Shares outstanding up 725.3% in 3 years
Returns
XtalPi Holdings returns
$1,000 invested in XtalPi Holdings 1 year ago, on November 20, 2025, would be worth $472 today: −52.76% in total, −52.76% per year. This is the price return only: dividends are excluded.
| Period | XtalPi Holdings | Hang Seng | $1,000 becomes |
|---|---|---|---|
| 1 month | −21.12% | −6.10% | $789 |
| 6 months | −39.24% | −12.63% | $608 |
| Year to date | −49.26% | −12.56% | $507 |
| 1 year | −52.76% | −13.26% | $472 |
Over the last 6 months it has done better than 5% of the stocks in the Healthcare sector.
Price only, without dividends. Calculate your investment
The chart in detail
XtalPi Holdings: technical analysis
XtalPi Holdings is in a downtrend: the price is below its 50- and 200-session moving averages, and the 200-session average is falling. The price is 69.2% below its all-time closing high ($15.60, September 10, 2024).
- Trend
- Downward
- RSI (14 sessions)
- 26
- Below 30: a strong fall in a short time
- vs 200-session average
- −40.97%
Active signals
New 52-week low.
since November 16, 2026
Close below the low of the previous 55 sessions.
RSI below 30: the stock has fallen a lot in a short time.
Support and resistance
Price areas where XtalPi Holdings has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance$6.75+40.63%2 touches, last on September 14, 2026
- Resistance$6.38+32.97%4 touches, last on November 10, 2026
- Resistance$5.67+18.13%2 touches, last on November 3, 2026
- Last price$4.80
- No support below: the price is near the lows of the year
Volatility and risk
Over the last year it has moved more than the Hang Seng.
- Beta (1 year) vs Hang Seng
- 1.35
- Volatility (60 sessions, annualised)
- 63.4%
- Largest fall in the last year
- −65.64%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
The company
XtalPi Holdings and its competitors
XtalPi Holdings Limited operates a research platform in Mainland China, the United States and other markets. Its offerings include XmartChem, an intelligent synthesis workstation that automates chemical synthesis, PatSight, a tool that extracts chemical structures from patents, and XMolGen, a generative chemistry tool. It also provides drug discovery solutions, from hit discovery to lead optimization, and peptide design through PepiX. Partners include Pfizer, with which it co-builds an AI-driven molecular simulation platform, and DoveTree, for therapeutics targeting difficult-to-drug targets.
- Headquarters
- Shenzhen, China
- Employees
- 1,623
- Founded
- 2015
- Chief executive
- Jian Ma
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| XtalPi Holdings2228 | $3B | -124.6% | — | −39.24% |
| M32413 | $7.04B | 19.5% | 24.4 | +19.18% |
| 4DMedical4DX | $867.27M | -813.7% | — | −34.15% |
| Pro MedicusPME | $13.08B | 74.9% | 76.0 | +45.89% |
| DoximityDOCS | $5.13B | 27.1% | 39.9 | +44.66% |
| Tempus AITEM | $9.86B | -18.5% | — | +17.79% |
Same industry or related industries, similar size. Compare XtalPi Holdings with its competitors · Full profile
